Epsilon M&A Deal Report - Penn T
Transaction Multiples for the Valuation of Private Companies
Celgene / Penn T
No EMAT :
17248
Announced Date :
21/10/2004
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Celgene
Target :
Penn T
Country :
Wales
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Health, Pharmaceuticals & Biotechnology > Biotechnology
Business Description :
Manufactures pharmaceuticals > Prior to the acquisition, celgene and Penn T were parties to a manufacturing agreement pursuant to which Penn T manufactured Thalomid (R) for celgene
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
|
|
| Current |
|
|
|
|
|
|
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
- Number of EMAT Reports / sub-sector « Biotechnology » = 43
| Date | Acquirer | Target | Country | Multiples | See details |
| 11/10/2005 | Southern Cross Healthcare | St Oswald's House | United Kingdom | * | 17240 |
| 01/09/2006 | Opica | Capio | Sweden | *** | 17238 |
Source: Epsilon Research / EMAT
